Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers.
Ann Gastroenterol
; 32(4): 392-399, 2019.
Article
en En
| MEDLINE
| ID: mdl-31263362
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Observational_studies
Idioma:
En
Revista:
Ann Gastroenterol
Año:
2019
Tipo del documento:
Article